16
Jan
Belgian drugmaker UCB has inked a $480 million deal to team up with Neuropore Therapies on some early-stage treatments for Parkinson’s disease.
Source: UCB taps Neuropore in a $480M Parkinson’s collaboration
Belgian drugmaker UCB has inked a $480 million deal to team up with Neuropore Therapies on some early-stage treatments for Parkinson’s disease.
Source: UCB taps Neuropore in a $480M Parkinson’s collaboration
